How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,563 results for

Preoperative Guidelines for Medications Prior to Surgery

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

–lung-sparing cytoreductive surgery (EPP), preferably in centres of excellence with experience in this modality for mesothelioma (Type of recommendation: evidence based; Evidence quality: intermediate; Strength of recommendation: strong). ENDORSED Recommendation 4.2: Hemithoracic neo-adjuvant radiation therapy may be offered to patients who undergo non–lung-sparing cytoreductive surgery. This potentially toxic regimen remains experimental and should only be performed in highly ENDORSED Guideline (...) who undergo lung-sparing surgical cytoreductive surgery, except under the context of a clinical trial. Justification for modifications to Recommendation 5.2: The word hemithoracic was added for clarity since this type of radiation therapy demonstrated severe pulmonary toxicity as mentioned in the ASCO guideline. ENDORSED with adaptations Recommendation 6.1: For palliative radiation therapy, electrons, 2D, 3D, and IMRT may be considered appropriate techniques depending on location of the treatment

2018 Cancer Care Ontario

82. Management of Venous Leg Ulcers: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Full Text available with Trip Pro

Committee—Venous Leg Ulcer Chair: Thomas F. O’Donnell Jr, MD (Cardiovascular Center, Tufts Medical Center, Boston, Mass) Vice Chair: Marc A. Passman, MD (Division of Vascular Surgery and Endovascular Therapy. University of Alabama at Birmingham, Birmingham, Ala; Birmingham Veterans Administration Medical Center, Birmingham, Ala) Committee Members: Mary E. Cummings, MD (University of Michigan, Ann Arbor, Mich) Michael C. Dalsing, MD (Indiana University School of Medicine, IU Health Care System (...) interventional therapies to prevent venous leg ulcer. [GRADE - 2; LEVEL OF EVIDENCE - C] Rationale for Venous Leg Ulcer Guidelines Guidelines present a synthesis of evidence-based recommendations for the diagnosis and treatment of a specific medical condition. x 1 Committee on Clinical Practice Guidelines, Institute of Medicine. Guidelines for clinical practice: From development to use. National Academy Press , Washington, DC ; 1992 The value of a guideline is that it provides consistency among treatment

2014 American Venous Forum

83. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

recommendations on the basis of the systematic review and denotes them with superscripted “SR” (i.e., SR ) to emphasize support derived from formal systematic review. Guideline-Directed Medical Therapy—Recognizing advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force designated the term “guideline-directed medical therapy” (GDMT) to represent recommended medical therapy as defined mainly by Class I measures—generally a combination of lifestyle modification and drug (...) . Exercise Stress Testing for Myocardial Ischemia and Functional Capacity: Recommendations 33 5.4. Cardiopulmonary Exercise Testing: Recommendation 34 5.5. Pharmacological Stress Testing 35 5.5.1. Noninvasive Pharmacological Stress Testing Before Noncardiac Surgery: Recommendations 35 5.5.2. Radionuclide MPI 36 5.5.3. Dobutamine Stress Echocardiography 36 5.6. Stress Testing—Special Situations 37 5.7. Preoperative Coronary Angiography: Recommendation 38 6. Perioperative Therapy 39 6.1. Coronary

2014 Society for Cardiovascular Angiography and Interventions

84. Guidelines for Laparoscopic Peritoneal Dialysis Access Surgery

Stefanidis, MD, PhD, Raymond Price, MD, Robert D. Fanelli, MD, Todd Penner, MD, William Richardson, MD SAGES Guidelines Committee Corresponding Author: Stephen P. Haggerty, MD, FACS Division of General Surgery NorthShore University Healthsystem, Evanston, IL Clinical Assistant Professor of Surgery University of Chicago Pritzker School of Medicine 777 Park Avenue West, #3464 Highland Park, IL 60035 847-570-1700 Preamble The use of peritoneal dialysis (PD) as a primary mode of renal replacement therapy has (...) . It will also review evaluation and management of malfunctioning catheters, again focusing on laparoscopic surgical techniques. PATIENT SELECTION Guideline recommendation Contraindications for laparoscopic PD catheter placement include active abdominal infection and uncorrectable mechanical defects of the abdominal wall (+++ Evidence, Strong recommendation) History of prior abdominal surgery, regardless of how many, is not a contraindication to laparoscopic PD catheter insertion. It is appropriate

2014 Society of American Gastrointestinal and Endoscopic Surgeons

85. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary

-Lead Electrocardiogram 2221 4.2. Assessment of Left Ventricular Function 2223 4.3. Exercise Testing 2223 4.4. Noninvasive Pharmacological Stress Testing Before Noncardiac Surgery 2224 4.5. Preoperative Coronary Angiography 2224 Perioperative Therapy: Recommendations 2224 5.1. Coronary Revascularization Before Noncardiac Surgery 2224 5.2. Timing of Elective Noncardiac Surgery in Patients With Previous PCI 2224 5.3. Perioperative Beta-Blocker Therapy 2226 5.4. Perioperative Statin Therapy 2227 5.5 (...) to the guideline topic lends itself to systematic review and analysis when the systematic review could impact the sense or strength of related recommendations. The GWC develops recommendations on the basis of the systematic review and denotes them with superscripted “SR” (ie, SR ) to emphasize support derived from formal systematic review. Guideline-Directed Medical Therapy —Recognizing advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force designated the term “guideline

2014 American Heart Association

86. Perioperative Cardiovascular Evaluation and Care For Noncardiac Surgery: Guidelines on

: Recommendation .e99 6.PERIOPERATIVE THERAPY e99 6.1. Coronary Revascularization Before Noncardiac Surgery: Recommendations... e100 Fleisher et al. JACC VOL. 64, NO. 22, 2014 ACC/AHA Perioperative Clinical Practice Guideline DECEMBER 9, 2014:e77–137 e786.1.1. Timing of Elective Noncardiac Surgery in Patients With Previous PCI: Recommendations . e100 6.2. Perioperative Medical Therapy ... e102 6.2.1. Perioperative Beta-Blocker Therapy: Recommendations . e102 6.2.1.1. Evidence on Ef?cacy of Beta-Blocker Therapy (...) with superscripted “SR” (i.e., SR ) to emphasize support derived from formal systematic review. Guideline-Directed Medical Therapy—Recognizing ad- vances in medical therapy across the spectrum of car- diovascular diseases, the Task Force designated the term “guideline-directed medical therapy” (GDMT) to repre- sent recommended medical therapy as de?ned mainly by Class I measures—generally a combination of lifestyle modi?cationanddrug-anddevice-basedtherapeutics.As medicalscience advances,GDMT evolves,and hence

2014 American College of Cardiology

87. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

of the systematic review and denotes them with superscripted “SR” (ie, SR ) to emphasize support derived from formal systematic review. Guideline-Directed Medical Therapy —Recognizing ad vances in medical therapy across the spectrum of cardiovascular diseases, the Task Force designated the term “guideline-directed medical therapy” (GDMT) to represent recommended medical therapy as defined mainly by Class I measures—generally a combination of lifestyle modification and drug- and device-based therapeutics (...) and Functional Capacity: Recommendations e295 5.4. Cardiopulmonary Exercise Testing: Recommendation e295 5.5. Pharmacological Stress Testing e296 5.5.1. Noninvasive Pharmacological Stress Testing Before Noncardiac Surgery: Recommendations e296 5.5.2. Radionuclide MPI e296 5.5.3. Dobutamine Stress Echocardiography e297 5.6. Stress Testing—Special Situations e297 5.7. Preoperative Coronary Angiography: Recommendation e297 Perioperative Therapy e298 6.1. Coronary Revascularization Before Noncardiac Surgery

2014 American Heart Association

88. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary

the spectrum of cardiovascular diseases, the Task Force designated the term “guideline-directed medical therapy” (GDMT) to represent recommended medical therapy as defined mainly by Class I measures—generally a combination of lifestyle modification and drug- and device-based therapeutics. As medical science advances, GDMT evolves, and hence GDMT is preferred to “optimal medical therapy.” For GDMT and all other recommended drug treatment regimens, the reader should confirm the dosage with product insert (...) . Multivariate Risk Indices: Recommendations 13 3.2. Stepwise Approach to Perioperative Cardiac Assessment: Treatment Algorithm 13 4. Supplemental Preoperative Evaluation: Recommendations 15 4.1. The 12-Lead Electrocardiogram 15 4.2. Assessment of Left Ventricular Function 16 4.3. Exercise Testing 16 4.4. Noninvasive Pharmacological Stress Testing Before Noncardiac Surgery 17 4.5. Preoperative Coronary Angiography 17 5. Perioperative Therapy: Recommendations 18 5.1. Coronary Revascularization Before

2014 Society for Cardiovascular Angiography and Interventions

89. Prevention of Acute Nausea and Vomiting due to Antineoplastic Medication in Pediatric Cancer Patients

: Additional Literature Search: Dronabinol and Levomepromazine 142 Appendix E: Quality of Evidence and Strength of Recommendation 148 Appendix F: Tables of Included Studies 149 F.1 Summary of studies used to inform recommendation #2a 149 F.1a Highly emetogenic antineoplastic therapy as ranked by POGO Guideline for Classification of the Acute Emetogenic Potential of antineoplastic Medication in Pediatric Cancer Patients 5 Version date: February 28, 2013 F.1b Highly emetogenic antineoplastic therapy (...) as ranked by study investigators where insufficient information available to assign emetogenic risk using the POGO Guideline for Classification of the Acute Emetogenic Potential of antineoplastic Medication in Pediatric Cancer Patients F.2 Summary of studies used to inform recommendation #2b 154 F.2a Moderately emetogenic antineoplastic therapy as ranked by POGO Guideline for Classification of the Acute Emetogenic Potential of antineoplastic Medication in Pediatric Cancer Patients F.2b Moderately

2013 SickKids Supportive Care Guidelines

90. Adjuvant systemic therapy for early stage (lymph node negative and lymph node positive) breast cancer

and are a synthesis of currently accepted approaches to management, derived from a review of relevant scientific literature. Clinicians applying these guidelines should, in consultation with the patient, use independent medical judgment in the context of individual clinical circumstances to direct care. All cancer drugs described in the guidelines are funded in accordance with the Outpatient Cancer Drug Benefit Program, at no charge, to eligible residents of Alberta, unless otherwise explicitly stated (...) score:* higher risk 3-5 * Examples: Prosigna TM , OncotypeDx® 6 CLINICAL PRACTICE GUIDELINE BR-014 Version 5 Page 4 of 11 Table 2. Genomic Testing for Systemic Therapy Decision Making* 3-5 Inclusion Criteria Exclusion Criteria • Patient is medically fit to receive adjuvant breast cancer chemotherapy AND • Has early stage resected lymph node negative (including N0i+) or N1mi AND • Either grade 2 or grade 3 invasive breast cancer • Patients unwilling to consider or are medically unfit to receive

2016 CPG Infobase

91. Preoperative Admission

of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. Copyright © 2018. AIM Specialty Health. All Rights Reserved. Preoperative Admission 4 Preoperative Admission Guidelines for Musculoskeletal Surgery and Procedures Description (...) and General Requirements The intent of this guideline is to assist in determining appropriate indications for hospital admission prior to elective surgery. The vast majority of musculoskeletal procedures do not require preoperative day admission. Providers should be prepared to submit the required supporting medical documentation to include but not limited to: • Provider office notes detailing preoperative medical optimization* • List of managed or unmanaged comorbidities and/or other surgical risk

2018 AIM Specialty Health

92. American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations Full Text available with Trip Pro

or outpatient clinical care and/or conducting interventions with specific clinical populations in the community setting (eg, cancer survivors, persons with HIV)—primarily dietitians, nurses, pharmacists, physicians, or researchers in relevant biomedical fields. These guidelines do not constitute medical or other professional advice and should not be taken as such. To the extent that the information published herein may be used to assist in the care of patients, this is the result of the sole professional (...) judgment of the attending healthcare professional whose judgment is the primary component of quality medical care. The information presented in these guidelines is not a substitute for the exercise of such judgment by the healthcare professional. Circumstances in clinical settings and patient indications may require actions different from those recommended in this document, and in those cases, the judgment of the treating professional should prevail. Methods All ASPEN guidelines since 2011 have

2019 American Society for Parenteral and Enteral Nutrition

93. Incontinence after Prostate Treatment: AUA/SUFU Guideline (2019)

, and treatment of BPH. Evaluation of the patient; risk factors for IPT, which should be discussed with all patients prior to treatment; assessment of the patient prior to intervention; and a stepwise approach to management are covered in this guideline. Possible maneuvers to decrease rates of IPT, with specific focus placed on patients with SUI, are also explored. The multiple treatments that exist for patients with IPT are discussed and evaluated, including physical therapy, medications, and surgery (...) , including physical therapy, medications, and surgery. Methodologies The systematic review utilized to inform this guideline was conducted by a methodology team at the Mayo Clinic Evidence-Based Practice Research Program. The scope of the topic and the discussion of the final systematic review used to develop guideline statements was conducted in conjunction with the Incontinence after Prostate Treatment expert panel. A research librarian conducted searches in Ovid MEDLINE (from 2000 to December 21 st

2019 Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction

94. Global Vascular Guidelines for patients with chronic limb-threatening ischemia Full Text available with Trip Pro

(Steering Committee) d , x Florian Dick Affiliations Department of Vascular Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland , MD (Steering Committee) e , x Robert Fitridge Affiliations Department of Vascular and Endovascular Surgery, The University of Adelaide Medical School, Adelaide, South Australia , MBBS (Steering Committee) f , x Joseph L. Mills Affiliations Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, Tex , MD (Steering Committee) g , x (...) of the trial steering committee for a randomized clinical trial of stem cells for the treatment of critical limb ischemia (PACE study, Pluristem Therapeutics, Inc) Prasad Jetty Division of Vascular and Endovascular Surgery, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada 10 None Kimihiro Komori Nagoya University Graduates School of Medicine, Japan 2, 6 None Lawrence Lavery UT Southwestern Medical Center, US 3, 8 Research grant, Cardinal Consultant/advisor: Aplion Medical Users, Harbor

2019 Society for Vascular Surgery

95. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Full Text available with Trip Pro

surgery or another invasive procedure in a given year ( x 2 Douketis, J.D., Berger, P.B., Dunn, A.S. et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest . 2008 ; 133 : 299S–339S ) (2) . However, data to guide interventionalists on the periprocedural management of patients with coagulopathies or those receiving anticoagulation and/or antiplatelet medications continue to be limited (...) (second edition): guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med . 2018 ; 43 : 225–262 , x 33 Birnie, D.H., Healey, J.S., Wells, G.A , and BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption

2019 Society of Interventional Radiology

96. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults Full Text available with Trip Pro

for other works by this author on: Torsten Meyer City Hospital Braunschweig, Braunschweig, Germany Search for other works by this author on: Sotirios Mikros Thriassion General Hospital, Athens, Greece Search for other works by this author on: Ionut Nistor ERBP, guideline development body of ERA-EDTA, London, UK University of Medicine and Pharmacy, Iasi, Romania Search for other works by this author on: Nils Planken Amsterdam University Medical Center, Amsterdam, The Netherlands Search for other works (...) . The second part—under development when this guideline went to press—will cover aspects related to access choice, preoperative vessel assessment and central venous catheters. We hope the current and planned CPG will assist the professional community in making decisions about vascular access processes, pathways and care; help patients and caregivers gain insight and facilitate joint decision making in this field. SUMMARY OF THE RECOMMENDATIONS Chapter 1. Medical treatments for promoting arteriovenous

2019 European Renal Best Practice

97. Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline

that portend a higher risk of cancer recurrence and that these findings may suggest a potential benefit of additional therapy after surgery. (Clinical Principle) Guideline Statement 2. Patients with adverse pathologic findings including seminal vesicle invasion, positive surgical margins, and extraprostatic extension should be informed that adjuvant radiotherapy, compared to radical prostatectomy only, reduces the risk of biochemical recurrence, local recurrence, and clinical progression of cancer (...) . Congruent with this clinical principle, physicians should regularly monitor PSA after radical prostatectomy to enable early administration of salvage therapies if appropriate. (Clinical Principle) Guideline Statement 5. Clinicians should define biochemical recurrence as a detectable or rising PSA value after surgery that is > 0.2 ng/ml with a second confirmatory level > 0.2 ng/ml. (Recommendation; Evidence Strength: Grade C) Guideline Statement 6. A restaging evaluation in the patient with a PSA

2019 American Urological Association

98. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures

to residual prolonged drug effects may lead to airway obstruction. , , In particular, promethazine (Phenergan; Wyeth Pharmaceuticals, Philadelphia, PA) has a “black box warning” regarding fatal respiratory depression in children younger than 2 years. Although the liquid formulation of chloral hydrate is no longer commercially available, some hospital pharmacies now are compounding their own formulations. Low-dose chloral hydrate (10–25 mg/kg), in combination with other sedating medications, is used (...) used for procedural sedation. An important concern for the practitioner is the widespread use of medications that may interfere with drug absorption or metabolism and therefore enhance or shorten the effect time of sedating medications. Herbal medicines (eg, St John’s wort, ginkgo, ginger, ginseng, garlic) may alter drug pharmacokinetics through inhibition of the cytochrome P450 system, resulting in prolonged drug effect and altered (increased or decreased) blood drug concentrations (midazolam

2019 American Academy of Pediatrics

99. Clinical Practice Guidelines for Surveillance Colonoscopy

summary of the recommendations. The complete guideline and technical documentation can be accessed online: wiki.cancer.org.au/australia/Guidelines:Colorectal_cancer/Colonoscopy_surveillance. Please also access the guidelines website for the latest version of the short-form summary. This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from Cancer Council Australia. Requests and enquiries (...) of this document were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 7 December 2018 under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. This ap- proval is valid for a period of five years. NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification

2019 Cancer Council Australia

100. AIM Clinical Appropriateness Guidelines for Advanced Imaging of the Heart.

). CPT ® five digit codes, nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. Description and Application of the GuidelinesGuideline Description and Administrative Guidelines | Copyright © 2019. AIM Specialty Health. All Rights Reserved. 4 Requests for multiple imaging studies to evaluate (...) condition for an individual. As used by AIM, the Guidelines establish objective and evidence-based, where possible, criteria for medical necessity determinations. In the process, multiple functions are accomplished: ? To establish criteria for when services are medically necessary ? To assist the practitioner as an educational tool ? To encourage standardization of medical practice patterns ? To curtail the performance of inappropriate and/or duplicate services ? To advocate for patient safety concerns

2019 AIM Specialty Health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>